Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:28 PM ET 8-K
Capital Raise FMC Corp FMC

FMC Capital Raise of $403M

FMC Corporation completed a $403.2 million equity investment from Tessenderlo Group NV, which purchased approximately 30.3 million shares to reach a 20% ownership stake. As part of the deal, Tessenderlo Group gains the right to nominate one independent director to the FMC Board and is subject to a three-year lock-up period and customary standstill restrictions.

Value
$403M
Counterparty
Tessenderlo Group NV
4:27 PM ET 8-K
Capital Raise KKR Infrastructure Conglomerate LLC

KKR Infrastructure Conglomerate Capital Raise of $205M

KKR Infrastructure Conglomerate LLC sold approximately $205.3 million in unregistered Class I, Class S, and Class D shares for cash on September 1, 2026. This sale is part of a continuous private offering that has raised approximately $7,979 million since the company's inception in June 2023.

Value
$205M
Counterparty
Accredited and non-U.S. investors
4:22 PM ET 8-K
Capital Raise Teamshares Inc TMS

Teamshares Capital Raise of $223M

Teamshares Inc. closed a $222.75 million preferred equity investment through the sale of 225,000 shares of newly designated Series A Preferred Stock to affiliates of T. Rowe Price. The non-convertible, non-voting perpetual preferred stock was issued at $990 per share (a 1% original issue discount) and is intended to fund the company's programmatic acquisition strategy of small and medium-sized enterprises.

Value
$223M
Counterparty
T. Rowe Price Investment Management, Inc.
4:18 PM ET 8-K
M&A Deal Theravance Biopharma, Inc. TBPH

Theravance Biopharma M&A Deal with Zymeworks Inc.

Theravance Biopharma, Inc. completed its merger with Zymeworks Inc., becoming a wholly owned subsidiary of Zymeworks. Shareholders received $17.00 in cash per share plus one contingent value right (CVR) per share. The transaction was finalized on September 23, 2026, following the original merger agreement signed in June 2026.

Counterparty
Zymeworks Inc.
4:15 PM ET 8-K
Capital Raise Blue Owl Credit Income Corp. OCIC

Blue Owl Credit Income Capital Raise of $1.75M

Blue Owl Credit Income Corp. sold 191,466 unregistered Class I common shares for $1.75 million in a private placement to feeder vehicles. The company also provided an update on its continuous public offering, which has raised approximately $22.5 billion in total proceeds to date across its public and private offerings.

Value
$1.75M
Counterparty
feeder vehicles
4:14 PM ET 8-K
Capital Raise Leader's Advantage Acquisition Corp. LEDR

Leader's Advantage Acquisition Capital Raise of $150M

Leader’s Advantage Acquisition Corp. consummated its initial public offering (IPO) of 15,000,000 units at $10.00 per unit, generating gross proceeds of $150 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with the units trading on Nasdaq under the symbol LEDRU. The company has granted underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.

Value
$150M
Counterparty
Clear Street LLC
4:12 PM ET 8-K
Clinical Trial Data Arcturus Therapeutics Holdings Inc. ARCT

Arcturus Therapeutics Holdings Clinical Trial Data

Arcturus Therapeutics released Phase 2 clinical data for ARCT-810, its mRNA-based therapeutic candidate for Ornithine Transcarbamylase (OTC) deficiency. The company also provided a strategic update on its broader mRNA delivery platform and technology pipeline.

4:06 PM ET 8-K
Clinical Trial Data Evommune, Inc. EVMN

Evommune Clinical Trial Data

Evommune announced that Phase 2a proof-of-concept data for EVO301, its IL-18 binding protein candidate for moderate-to-severe atopic dermatitis, will be presented in a late-breaking oral session at the EADV 2026 Congress. The presentation will build on topline results reported earlier in the year as the company prepares to initiate a Phase 2b dose-ranging study in mid-2027.

Counterparty
European Academy of Dermatology & Venereology (EADV)
4:06 PM ET 8-K
Capacity Expansion Evofem Biosciences, Inc. EVFM

Evofem Biosciences Capacity Expansion

Evofem Biosciences entered into a manufacturing agreement with Zhaoke Ophthalmology Pharmaceutical Limited to establish a second production source for its contraceptive gel, PHEXX. The expansion is designed to enhance supply chain flexibility and is expected to reduce unit costs by 40% or more once regulatory approval for the new facility is obtained.

Counterparty
Zhaoke Ophthalmology Pharmaceutical Limited
4:02 PM ET 8-K
Clinical Trial Data Longeveron Inc. LGVN

Longeveron Clinical Trial Data

Longeveron announced that its Phase 2b ELPIS II trial evaluating laromestrocel for hypoplastic left heart syndrome (HLHS) failed to meet its primary efficacy endpoint of change in right ventricular ejection fraction at 12 months. Despite the failure, the company noted a favorable safety profile and plans to discuss exploratory clinical outcomes with the FDA to determine potential next steps. Consequently, the company has initiated cost containment measures and is exploring options to maximize shareholder value.

3:54 PM ET 8-K
M&A Deal Apogee Enterprises, Inc. APOG

Apogee Enterprises M&A Deal with GroGlass

Apogee Enterprises completed the acquisition of SIA “Alzette” and its subsidiaries, including GroGlass, a Latvian provider of high-performance anti-reflective glass coatings. The transaction values GroGlass at €62.5 million on a cash-free, debt-free basis, with an additional contingent earnout of up to €10 million based on financial performance over three years. The acquisition was funded through available cash and borrowings under the company's existing revolving credit facility.

Counterparty
GroGlass
3:50 PM ET 8-K
Capital Raise AB Private Credit Investors Corp

AB Private Credit Investors Capital Raise of $8.74M

AB Private Credit Investors Corp delivered a capital call notice to its investors for an aggregate offering price of approximately $8.74 million. The sale of common stock is being conducted under existing subscription agreements where investors fund capital commitments on an as-needed basis. The transaction is expected to close on or around October 1, 2026.

Value
$8.74M
2:33 PM ET 8-K
M&A Deal Columbus Acquisition Corp COLAU

Columbus Acquisition M&A Deal with WISeSat.Space Corp

Columbus Acquisition Corp announced that its reconvened Extraordinary General Meeting to approve the business combination with WISeSat.Space Corp will be held on September 28, 2026. The meeting was previously adjourned on September 10, 2026, and the company has established a new extended redemption deadline of September 24, 2026, for shareholders.

Counterparty
WISeSat.Space Corp
12:05 PM ET 8-K/A
Product Launch SharonAI Holdings Inc. SHAZ

SharonAI Holdings Product Launch

SharonAI Holdings announced a collaboration with VAST Data to launch DataEnclave, a confidential AI capability integrated into Sharon AI’s AI Factory platform across Australia and Asia-Pacific. The service provides hardware-isolated secure runtimes and cryptographic attestation, allowing regulated organizations like banks and government agencies to run advanced AI models onshore without exposing sensitive data or model weights.

Counterparty
VAST Data
11:35 AM ET 8-K
Nasdaq/NYSE Compliance Notice Aditxt, Inc. ADTX

Aditxt Nasdaq/NYSE Compliance Notice

Aditxt, Inc. received notice that Nasdaq will file a Form 25 with the SEC to formally complete the delisting of its common stock, following a suspension of trading that began on June 25, 2026. The delisting will become effective ten days after the filing, and the company's common stock currently trades on the OTC Market.

Counterparty
The Nasdaq Stock Market LLC
10:43 AM ET 8-K
M&A Deal Ondas Inc. ONDS

Ondas M&A Deal with CaribouLabs Ltd.

Ondas Inc. acquired three defense technology businesses—CaribouLabs, Insignito Solutions, and Ottopia Technologies—to expand its autonomous defense systems platform. The acquisitions were completed via the issuance of 7,821,445 shares of common stock to the sellers, and the company filed a prospectus supplement to facilitate the resale of these shares.

Counterparty
CaribouLabs Ltd., Insignito Solutions Ltd., and Ottopia Technologies Ltd.
10:12 AM ET 8-K
Capacity Expansion Quanome Technologies, Inc. QNME

Quanome Technologies Capacity Expansion: $18.8M Investment

Quanome Technologies entered into an $18.8 million purchase agreement for NVIDIA GPU-powered computing infrastructure to build its first U.S. AI infrastructure hub. The project, managed through its subsidiary XDT, aims to provide businesses with scalable AI cloud computing capacity and is expected to be operational starting in Q4 2026.

Value
$18.8M
Counterparty
XDT Infrastructure I, LLC

“This investment puts Quanome’s commitment to quantum and AI into action. Through XDT, we aim to give more businesses access to advanced AI computing to power their growth. Our priorities are clear: launch our first hub, grow a strong client base and build recurring revenue to deliver long-term shareholder value.”

Yang Li, Chief Executive Officer of Quanome Technologies
9:25 AM ET 8-K
Nasdaq/NYSE Compliance Notice Greenland Technologies Holding Corp. GTEC

Greenland Technologies Holding Nasdaq/NYSE Compliance Notice

Greenland Technologies Holding Corporation has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The company's Class A ordinary shares maintained a closing bid price of at least $1.00 for 10 consecutive business days from September 8 to September 21, 2026. Nasdaq has officially closed the matter, resolving the deficiency notice originally issued in March 2026.

Counterparty
The Nasdaq Stock Market LLC
9:16 AM ET 8-K
Product Launch Game Your Game Inc. GYGY

Game Your Game Product Launch

Game Your Game Inc. announced the full commercial availability of GameGolf KZN AI, its next-generation AI-powered golf performance platform. The platform integrates automatic shot tracking, advanced GPS, and AI analytics to provide personalized performance insights and on-course strategy for golfers.

9:00 AM ET 8-K
M&A Deal Caesars Entertainment, Inc. CZR

Caesars Entertainment Signs $6.32B M&A Deal with Fertitta Gaming Holdco, LLC

Caesars Entertainment stockholders voted to approve the previously announced merger agreement with Fertitta Gaming Holdco, LLC, under which Caesars will be acquired for $31.00 per share in cash. Approximately 65.4% of outstanding shares voted in favor of the deal, which will result in Caesars becoming a privately held, wholly owned subsidiary of Fertitta Gaming. The transaction includes a ticking fee of $0.007150 per share per day if the merger does not close by June 26, 2027.

Value
$6.32B
Counterparty
Fertitta Gaming Holdco, LLC
8:55 AM ET 8-K/A
M&A Deal reAlpha Tech Corp. AIRE

reAlpha Tech M&A Deal with InstaMortgage Inc.

reAlpha Tech Corp. completed its acquisition of InstaMortgage Inc. on August 19, 2026, with InstaMortgage becoming a wholly-owned subsidiary. This filing serves as an amendment to provide required historical financial statements and pro forma financial information related to the transaction.

Counterparty
InstaMortgage Inc.
8:30 AM ET 8-K
M&A Deal Accelerant Holdings ARX

Accelerant Holdings Signs $4B M&A Deal with Thoma Bravo

Accelerant Holdings announced the expiration of its 40-day 'go-shop' period without receiving any alternative acquisition proposals. The company remains on track to be acquired by affiliates of Thoma Bravo in an all-cash transaction valued at more than $4 billion, which will result in Accelerant becoming a private company.

Value
$4B
Counterparty
Thoma Bravo
Term
through first half of 2027
8:30 AM ET 8-K
Partnership Nocera, Inc. NCRA

Nocera Partnership with E-Pro Display Co., Ltd.

Nocera entered into a Strategic Partnership and Joint Distribution Agreement with E-PRO DISPLAY CO., LTD. to act as a worldwide distributor for pre-owned iPhone 17 Pro handsets. While the underlying program involves an allocation of 600,000 handsets valued at $520.5 million, the agreement is a framework with no minimum purchase commitments or guaranteed revenue for Nocera.

Counterparty
E-PRO DISPLAY CO., LTD.
Term
12 months
8:26 AM ET 8-K
Capital Raise Moleculin Biotech, Inc. MBRX

Moleculin Biotech Capital Raise

Moleculin Biotech raised $0.48 million in gross proceeds through the issuance of 888,400 shares under its at-the-market (ATM) offering program in September 2026. The issuance triggered an anti-dilution provision in the company's Series I Warrants, reducing their exercise price from $0.75 to $0.51 per share.

Counterparty
Roth Capital Partners, LLC
8:25 AM ET 8-K
M&A Deal Rain Enhancement Technologies Holdco, Inc. RAIN

Rain Enhancement Technologies Holdco M&A Deal with Tensor Networks, Inc.

Rain Enhancement Technologies Holdco, Inc. (RAIN) has entered into a binding letter of intent to acquire Tensor Networks, Inc., a developer of predictive AI infrastructure security technology. The all-stock transaction will result in Tensor Networks becoming a wholly owned subsidiary of RAIN, with Tensor equity holders expected to own approximately 90% of the combined company. The deal, expected to close in Q1 2027, transforms RAIN into a multi-technology holding company.

Counterparty
Tensor Networks, Inc.
8:16 AM ET 8-K
Divestiture Greenpro Capital Corp. GRNQ

Greenpro Capital Divestiture to Ms. Chen Yanhong

Greenpro Capital Corp. entered into a share sale agreement to sell its entire equity interest in six subsidiaries, collectively known as the F&A Entities, to Ms. Chen Yanhong for approximately $0.45 million in cash. The F&A Entities provide corporate advisory and company-secretarial services in Hong Kong and China. The company intends to use the proceeds for general corporate purposes and working capital.

Counterparty
Ms. Chen Yanhong
8:01 AM ET 8-K
Nasdaq/NYSE Compliance Notice Lakeshore Acquisition III Corp. LCCC

Lakeshore Acquisition III Nasdaq/NYSE Compliance Notice

Lakeshore Acquisition III Corp. received approval from Nasdaq to transfer the listing of its units, ordinary shares, and rights from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is effective at the opening of business on September 24, 2026, and the securities will continue to trade under their existing symbols (LCCCU, LCCC, and LCCCR).

Counterparty
Nasdaq
7:31 AM ET 8-K
Nasdaq/NYSE Compliance Notice Cytosorbents Corp CTSO

Cytosorbents Nasdaq/NYSE Compliance Notice

CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.

Counterparty
Nasdaq
Term
until Dec 28, 2026
7:30 AM ET 8-K
Cybersecurity Incident Astrana Health, Inc. ASTH

Astrana Health Cybersecurity Incident

Astrana Health disclosed a material cybersecurity incident involving social engineering and unauthorized access to its systems by threat actors impersonating company personnel. The company determined the incident is material as of September 22, 2026, due to the potential compromise of sensitive patient, employee, and provider data. Remedial actions including credential resets and system restorations have been implemented while a forensic investigation remains ongoing.

7:15 AM ET 8-K
Product Launch SharonAI Holdings Inc. SHAZ

SharonAI Holdings Product Launch

SharonAI Holdings announced a collaboration with VAST Data to launch DataEnclave, a confidential AI capability integrated into Sharon AI's AI Factory platform across Australia and Asia-Pacific. The service provides a hardware-isolated secure runtime for running advanced AI models onshore, allowing regulated organizations like banks and government agencies to process sensitive data without it leaving their controlled infrastructure.

Counterparty
VAST Data

“Our customers across Australia and Asia-Pacific need to run AI at full speed without compromising on data sovereignty, and increasingly they also want access to frontier models that were previously only available offshore. Building on our sovereign data foundation with VAST DataEnclave is expected to let us host those models onshore, inside attested environments where the model owner’s weights and the customer’s data are both protected from everyone, including us.”

James Manning, Co-founder and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.